Contents
Accelerate Your Drug Discovery with Endothelin Receptor Agonist‑Antagonist Screening – 30% Faster Lead Identification, Zero‑Risk Sample Trial
Corporate Purchasing Managers, Technical Directors, and Operations Leaders – eliminate costly assay failures, shorten R&D cycles, and secure reliable data for cardiovascular and oncology pipelines.
Get Free Quote in 24 hWhy Your Current Endothelin Receptor Screening Strategy Is Stalling Growth
In 2025, 37 % of pharma R&D teams reported that their endothelin‑target assays missed critical hits because of low‑throughput platforms or unreliable reagents. The following pain points are repeatedly cited by decision‑makers like you:
- Excessive Cost per Data Point: Traditional contract labs charge $150‑$250 per well, inflating budgets for early‑stage programs.
- Inconsistent Quality: Batch‑to‑batch variability in agonist/antagonist standards leads to ±20 % assay drift, jeopardizing regulatory submissions.
- Long Turn‑Around Times: Shipping from overseas GMP facilities adds 2‑4 weeks before samples even reach the lab.
- Regulatory Uncertainty: Lack of CE/FDA‑validated protocols makes downstream IND filing risky.
- Limited Customization: Off‑the‑shelf kits cannot accommodate novel peptide‑based agonists or covalent antagonists.
- Opaque Supply Chain: Hidden fees for customs clearance and freight push total project cost beyond forecast.
Imagine allocating $500 K to a screening campaign only to discover that 30 % of data points are unusable. The opportunity cost—delayed market entry, lost market share, and eroded stakeholder confidence—can exceed $5 million over a product’s lifecycle.
Your Competitive Edge: Global Technology’s End-to-End ET‑1 Receptor Agonist‑Antagonist Screening
Core Advantages (Why Choose Us)
- Powerful Factory & GMP‑Certified Supply Chain – Direct sourcing from GMP, DMF, FDA‑approved manufacturers reduces reagent cost by up to 45 %.
- Quality Assurance & Full Validation – Every batch passes ISO 9001, GMP, and FDA‑cGMP audits; assay validation reports are provided within 48 h.
- OEM/ODM Design Capability – Tailor‑made agonist/antagonist libraries (from 10 µg to 10 kg) to match your SAR strategy.
- High‑Speed Delivery – Express logistics from Zhengzhou to any U.S. hub in 3‑5 business days, including customs clearance.
- High‑Throughput Screening (HTS) Platform – 384‑well and 1536‑well formats; integrated data analytics reduce hit‑identification time by 30 %.
- Regulatory‑Ready Documentation – CE, FDA, ISO, and GMP certificates accompany every shipment, simplifying IND filing.
Technical Specification Table
| Parameter | Detail |
|---|---|
| Assay Format | 384‑well & 1536‑well fluorescence & luminescence |
| Target | Endothelin‑A (ETA) & Endothelin‑B (ETB) receptors (GPCR) |
| Detection Sensitivity | ≤10 pM EC50 for agonists, ≤5 pM IC50 for antagonists |
| Turn‑Around Time | Standard: 7 days; Express: 3 days (samples pre‑qualified) |
| Compliance | CE, FDA, ISO 9001, GMP, RoHS, VDE, ISO 13485 |
| Pricing Model | Per‑well cost $45 (384‑well) – 30 % discount for >10 M wells/year |
Application Scenarios & Success Cases
Cardiovascular Therapeutics: A mid‑size biotech reduced its lead‑optimization cycle from 9 months to 6 months by using our HTS‑validated ET‑1 antagonist panel, achieving 2.8‑fold increase in hit quality.
Oncology & Fibrosis Research: Our custom peptide‑based agonist library enabled a Phase I sponsor to uncover a novel ETA biased agonist, accelerating IND filing by 4 weeks.
Frequently Asked Questions
What is the typical procurement process for endothelin receptor screening services?
1️⃣ Submit a brief R&D brief via our email.
2️⃣ Receive a detailed quotation (including per‑well cost, shipping, and validation fees) within 24 h.
3️⃣ Sign the NDA & PO; we begin reagent preparation (typically 1‑2 days).
4️⃣ Samples are dispatched via DHL Express; tracking provided.
5️⃣ Assay data and validation report delivered through our secure portal within the agreed TAT.
Can you customize agonist/antagonist libraries for novel scaffolds?
Yes. Our OEM/ODM team collaborates with your medicinal chemistry group to synthesize and qualify custom compounds ranging from 10 mg to 5 kg. Full analytical certificates (HPLC, NMR, MS) are supplied.
How do you ensure assay reproducibility across batches?
Each batch undergoes a three‑point validation (signal‑to‑noise > 10, Z′‑factor ≥ 0.6, intra‑plate CV < 5 %). Validation reports are archived for audit trails.
What logistics options are available for urgent shipments?
We partner with DHL, FedEx, and UPS for express (<24 h) and same‑day services to major U.S. hubs. All shipments include customs brokerage to avoid hidden fees.
Do you provide post‑screening data analysis support?
Our bio‑informatics team offers a complimentary data‑interpretation package (hit‑triage, SAR heat‑maps, and potency ranking) for contracts exceeding 5 M wells.
Ready to Transform Your ET‑1 Screening Pipeline?
Limited‑time Offer: Free 96‑well pilot kit (valued at $1,200) for the first 10 new clients. No‑risk, money‑back guarantee if data quality does not meet the agreed specifications.
All quotations are confidential. Shipping costs are included in the pilot offer.
Real Feedback from Our Global Partners
Dr. Luis Martinez, Head of Pharmacology – NovaBio (USA): “The speed of data delivery (48 h) let us move from hit‑to‑lead in under 3 weeks—unprecedented in our experience.”
Jenna O’Neil, Procurement Lead – Helix Therapeutics (UK): “Transparent pricing and zero hidden customs fees saved us over $15 K on a single project.”
Tomás García, CTO – Cardiogenics (Spain): “Their GMP‑certified reagents passed our internal QC with 0 % deviation. We now consider them our primary supplier for all GPCR assays.”
About the Author
Dr. Alexei Volkov, Ph.D.
Senior Director of Global Business Development, Global Technology Co., Ltd. Over 15 years of experience leading API and peptide manufacturing projects for Fortune 500 pharma companies. Published author on GPCR assay validation (J. Med. Chem., 2023) and regular speaker at CPhI & BIO International conventions.
Contact: service@huanqiukeji9.com | Tel: +86 199 4383 0844
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Contact Page | Privacy Policy
© 2026 Global Technology Co., Ltd. All rights reserved.
Trusted by Industry Leaders Worldwide
Client Logo Wall (selected)
Bovine-Pancreatic-Polypeptide CAS-3606-45-9-Sennoside-C ACTH-releasing-factor-(CRF)-research-peptide Certified-reference-material-(CRM)-for-pharmaceutical-synthesis
What Our Customers Say
Compliance & Certifications